Literature DB >> 29968196

Progress in heart failure treatment in Germany.

Mark Luedde1, Martina E Spehlmann1, Norbert Frey2.   

Abstract

Acute and chronic heart failure is still a major cause of morbidity and mortality in Europe. Nevertheless, significant progress has been made in diagnosis and treatment of heart failure as well as in unraveling its molecular causes. Here, we focus on some relevant contributions to these achievements by German cardiovascular clinicians and scientists.

Entities:  

Keywords:  Biomarkers; Comorbidities; Heart failure; Structured care and education

Mesh：

Year:  2018        PMID： 29968196     DOI： 10.1007/s00392-018-1317-0

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


  80 in total

1.  Improving outcomes in heart failure: a personal perspective.

Authors:  John J J V McMurray
Journal:  Eur Heart J       Date:  2015-11-17       Impact factor: 29.983

2.  GDF-15 in heart failure: providing insight into end-organ dysfunction and its recovery?

Authors:  Kai C Wollert; Tibor Kempf
Journal:  Eur J Heart Fail       Date:  2012-10-08       Impact factor: 15.534

Review 3.  Symbiogenesis: the holobiont as a unit of evolution.

Authors:  Ricardo Guerrero; Lynn Margulis; Mercedes Berlanga
Journal:  Int Microbiol       Date:  2013-09       Impact factor: 2.479

4.  MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry.

Authors:  Stephan Baldus; Wolfgang Schillinger; Olaf Franzen; Raffi Bekeredjian; Horst Sievert; Joachim Schofer; Karl-Heinz Kuck; Thomas Konorza; Helge Möllmann; Christoph Hehrlein; Taoufik Ouarrak; Jochen Senges; Thomas Meinertz
Journal:  Eur J Heart Fail       Date:  2012-06-08       Impact factor: 15.534

5.  Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.

Authors:  Noritoshi Nagaya; Junji Moriya; Yoshio Yasumura; Masaaki Uematsu; Fumiaki Ono; Wataru Shimizu; Kazuyuki Ueno; Masafumi Kitakaze; Kunio Miyatake; Kenji Kangawa
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

6.  Growth-differentiation factor-15 in heart failure.

Authors:  Tibor Kempf; Kai C Wollert
Journal:  Heart Fail Clin       Date:  2009-10       Impact factor: 3.179

7.  Role of left ventricular stiffness in heart failure with normal ejection fraction.

Authors:  Dirk Westermann; Mario Kasner; Paul Steendijk; Frank Spillmann; Alexander Riad; Kerstin Weitmann; Wolfgang Hoffmann; Wolfgang Poller; Matthias Pauschinger; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690

8.  GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men.

Authors:  Lars Wallentin; Björn Zethelius; Lars Berglund; Kai M Eggers; Lars Lind; Bertil Lindahl; Kai C Wollert; Agneta Siegbahn
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

9.  Dysregulated long intergenic non-coding RNA modules contribute to heart failure.

Authors:  Lin Pang; Jing Hu; Guanxiong Zhang; Xiang Li; Xinxin Zhang; Fulong Yu; Yujia Lan; Jinyuan Xu; Bo Pang; Dong Han; Yun Xiao; Xia Li
Journal:  Oncotarget       Date:  2016-09-13

10.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Authors:  Jose Luis Zamorano; Patrizio Lancellotti; Daniel Rodriguez Muñoz; Victor Aboyans; Riccardo Asteggiano; Maurizio Galderisi; Gilbert Habib; Daniel J Lenihan; Gregory Y H Lip; Alexander R Lyon; Teresa Lopez Fernandez; Dania Mohty; Massimo F Piepoli; Juan Tamargo; Adam Torbicki; Thomas M Suter
Journal:  Eur Heart J       Date:  2016-08-26       Impact factor: 29.983
View more
  5 in total

1.  Severe eosinophilic myocarditis associated with modafinil in a patient with normal peripheral eosinophil count.

Authors:  Marina Bäuml; Josefina Udi; Karin Klingel; Christoph Bode; Klaus Warnatz; Andreas Zirlik; Daniel Duerschmied; Paul Biever
Journal:  Clin Res Cardiol       Date:  2019-02-12       Impact factor: 5.460

2.  Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population.

Authors:  Tobias Schupp; Ibrahim Akin; Linda Reiser; Armin Bollow; Gabriel Taton; Thomas Reichelt; Dominik Ellguth; Niko Engelke; Uzair Ansari; Kambis Mashayekhi; Christel Weiß; Christoph Nienaber; Muharrem Akin; Martin Borggrefe; Michael Behnes
Journal:  Clin Res Cardiol       Date:  2019-02-12       Impact factor: 5.460

3.  Heart failure and dementia: a comparative analysis with different types of cancer.

Authors:  Christoph Roderburg; Sven H Loosen; Markus S Jördens; Marcel Konrad; Tom Luedde; Karel Kostev; Mark Luedde
Journal:  Eur Heart J Open       Date:  2021-07-24

Review 4.  [Update on diagnostics and treatment of heart failure].

Authors:  Jan Wintrich; Ann-Kathrin Berger; Yvonne Bewarder; Insa Emrich; Jonathan Slawik; Michael Böhm
Journal:  Herz       Date:  2021-08-31       Impact factor: 1.740

5.  The spectrum of comorbidities at the initial diagnosis of heart failure a case control study.

Authors:  Sven H Loosen; Christoph Roderburg; Ole Curth; Julia Gaensbacher; Markus Joerdens; Tom Luedde; Marcel Konrad; Karel Kostev; Mark Luedde
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.